カテゴリー： Market Monitor Global, 世界, 医療/バイオ

顔面紅斑治療の世界市場見通し2023年-2029年

◆英語タイトル：Facial Erythema Therapies Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5555）

◆商品コード：MMG23JU5555
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：66
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Facial Erythema Therapies Market 調査レポートは次の情報を含め、グローバルにおけるの顔面紅斑治療市場規模と予測を収録しています。・世界の顔面紅斑治療市場：売上、2018年-2023年、2024年-2029年
・世界の顔面紅斑治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の顔面紅斑治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「Rx」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

顔面紅斑治療のグローバル主要企業は、Novartis、 Pfizer、 Sanofi-Aventis、 Merck、 Enzon Pharmaceuticals、 Bayer、 Astellas Pharma、 GSK、 Abbottなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、顔面紅斑治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の顔面紅斑治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の顔面紅斑治療市場：タイプ別市場シェア、2022年
・Rx、OTC

世界の顔面紅斑治療市場：用途別、2018年-2023年、2024年-2029年
世界の顔面紅斑治療市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の顔面紅斑治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の顔面紅斑治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における顔面紅斑治療のグローバル売上、2018年-2023年
・主要企業における顔面紅斑治療のグローバル売上シェア、2022年
・主要企業における顔面紅斑治療のグローバル販売量、2018年-2023年
・主要企業における顔面紅斑治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novartis、 Pfizer、 Sanofi-Aventis、 Merck、 Enzon Pharmaceuticals、 Bayer、 Astellas Pharma、 GSK、 Abbott

*************************************************************

・調査・分析レポートの概要
顔面紅斑治療市場の定義
市場セグメント
世界の顔面紅斑治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の顔面紅斑治療市場規模
世界の顔面紅斑治療市場規模：2022年 VS 2029年
世界の顔面紅斑治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの顔面紅斑治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の顔面紅斑治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：Rx、OTC
顔面紅斑治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
顔面紅斑治療の用途別グローバル売上・予測

・地域別市場分析
地域別顔面紅斑治療市場規模 2022年と2029年
地域別顔面紅斑治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis、 Pfizer、 Sanofi-Aventis、 Merck、 Enzon Pharmaceuticals、 Bayer、 Astellas Pharma、 GSK、 Abbott
...

Drugs for Facial Erythema
This report aims to provide a comprehensive presentation of the global market for Facial Erythema Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Facial Erythema Therapies. This report contains market size and forecasts of Facial Erythema Therapies in global, including the following market information:
Global Facial Erythema Therapies Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Facial Erythema Therapies market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Rx Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Facial Erythema Therapies include Novartis, Pfizer, Sanofi-Aventis, Merck, Enzon Pharmaceuticals, Bayer, Astellas Pharma, GSK and Abbott, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Facial Erythema Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Facial Erythema Therapies Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Facial Erythema Therapies Market Segment Percentages, by Type, 2022 (%)
Rx
OTC
Global Facial Erythema Therapies Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Facial Erythema Therapies Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Facial Erythema Therapies Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Facial Erythema Therapies Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Facial Erythema Therapies revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Facial Erythema Therapies revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Pfizer
Sanofi-Aventis
Merck
Enzon Pharmaceuticals
Bayer
Astellas Pharma
GSK
Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Facial Erythema Therapies, market overview.
Chapter 2: Global Facial Erythema Therapies market size in revenue.
Chapter 3: Detailed analysis of Facial Erythema Therapies company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Facial Erythema Therapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Facial Erythema Therapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Facial Erythema Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Facial Erythema Therapies Overall Market Size
2.1 Global Facial Erythema Therapies Market Size: 2022 VS 2029
2.2 Global Facial Erythema Therapies Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Facial Erythema Therapies Players in Global Market
3.2 Top Global Facial Erythema Therapies Companies Ranked by Revenue
3.3 Global Facial Erythema Therapies Revenue by Companies
3.4 Top 3 and Top 5 Facial Erythema Therapies Companies in Global Market, by Revenue in 2022
3.5 Global Companies Facial Erythema Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Facial Erythema Therapies Players in Global Market
3.6.1 List of Global Tier 1 Facial Erythema Therapies Companies
3.6.2 List of Global Tier 2 and Tier 3 Facial Erythema Therapies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Facial Erythema Therapies Market Size Markets, 2022 & 2029
4.1.2 Rx
4.1.3 OTC
4.2 By Type – Global Facial Erythema Therapies Revenue & Forecasts
4.2.1 By Type – Global Facial Erythema Therapies Revenue, 2018-2023
4.2.2 By Type – Global Facial Erythema Therapies Revenue, 2024-2029
4.2.3 By Type – Global Facial Erythema Therapies Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Facial Erythema Therapies Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Facial Erythema Therapies Revenue & Forecasts
5.2.1 By Application – Global Facial Erythema Therapies Revenue, 2018-2023
5.2.2 By Application – Global Facial Erythema Therapies Revenue, 2024-2029
5.2.3 By Application – Global Facial Erythema Therapies Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Facial Erythema Therapies Market Size, 2022 & 2029
6.2 By Region – Global Facial Erythema Therapies Revenue & Forecasts
6.2.1 By Region – Global Facial Erythema Therapies Revenue, 2018-2023
6.2.2 By Region – Global Facial Erythema Therapies Revenue, 2024-2029
6.2.3 By Region – Global Facial Erythema Therapies Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Facial Erythema Therapies Revenue, 2018-2029
6.3.2 US Facial Erythema Therapies Market Size, 2018-2029
6.3.3 Canada Facial Erythema Therapies Market Size, 2018-2029
6.3.4 Mexico Facial Erythema Therapies Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Facial Erythema Therapies Revenue, 2018-2029
6.4.2 Germany Facial Erythema Therapies Market Size, 2018-2029
6.4.3 France Facial Erythema Therapies Market Size, 2018-2029
6.4.4 U.K. Facial Erythema Therapies Market Size, 2018-2029
6.4.5 Italy Facial Erythema Therapies Market Size, 2018-2029
6.4.6 Russia Facial Erythema Therapies Market Size, 2018-2029
6.4.7 Nordic Countries Facial Erythema Therapies Market Size, 2018-2029
6.4.8 Benelux Facial Erythema Therapies Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Facial Erythema Therapies Revenue, 2018-2029
6.5.2 China Facial Erythema Therapies Market Size, 2018-2029
6.5.3 Japan Facial Erythema Therapies Market Size, 2018-2029
6.5.4 South Korea Facial Erythema Therapies Market Size, 2018-2029
6.5.5 Southeast Asia Facial Erythema Therapies Market Size, 2018-2029
6.5.6 India Facial Erythema Therapies Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Facial Erythema Therapies Revenue, 2018-2029
6.6.2 Brazil Facial Erythema Therapies Market Size, 2018-2029
6.6.3 Argentina Facial Erythema Therapies Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Facial Erythema Therapies Revenue, 2018-2029
6.7.2 Turkey Facial Erythema Therapies Market Size, 2018-2029
6.7.3 Israel Facial Erythema Therapies Market Size, 2018-2029
6.7.4 Saudi Arabia Facial Erythema Therapies Market Size, 2018-2029
6.7.5 UAE Facial Erythema Therapies Market Size, 2018-2029
7 Facial Erythema Therapies Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Facial Erythema Therapies Major Product Offerings
7.1.4 Novartis Facial Erythema Therapies Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Facial Erythema Therapies Major Product Offerings
7.2.4 Pfizer Facial Erythema Therapies Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Company Summary
7.3.2 Sanofi-Aventis Business Overview
7.3.3 Sanofi-Aventis Facial Erythema Therapies Major Product Offerings
7.3.4 Sanofi-Aventis Facial Erythema Therapies Revenue in Global Market (2018-2023)
7.3.5 Sanofi-Aventis Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Facial Erythema Therapies Major Product Offerings
7.4.4 Merck Facial Erythema Therapies Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Enzon Pharmaceuticals
7.5.1 Enzon Pharmaceuticals Company Summary
7.5.2 Enzon Pharmaceuticals Business Overview
7.5.3 Enzon Pharmaceuticals Facial Erythema Therapies Major Product Offerings
7.5.4 Enzon Pharmaceuticals Facial Erythema Therapies Revenue in Global Market (2018-2023)
7.5.5 Enzon Pharmaceuticals Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Facial Erythema Therapies Major Product Offerings
7.6.4 Bayer Facial Erythema Therapies Revenue in Global Market (2018-2023)
7.6.5 Bayer Key News & Latest Developments
7.7 Astellas Pharma
7.7.1 Astellas Pharma Company Summary
7.7.2 Astellas Pharma Business Overview
7.7.3 Astellas Pharma Facial Erythema Therapies Major Product Offerings
7.7.4 Astellas Pharma Facial Erythema Therapies Revenue in Global Market (2018-2023)
7.7.5 Astellas Pharma Key News & Latest Developments
7.8 GSK
7.8.1 GSK Company Summary
7.8.2 GSK Business Overview
7.8.3 GSK Facial Erythema Therapies Major Product Offerings
7.8.4 GSK Facial Erythema Therapies Revenue in Global Market (2018-2023)
7.8.5 GSK Key News & Latest Developments
7.9 Abbott
7.9.1 Abbott Company Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Facial Erythema Therapies Major Product Offerings
7.9.4 Abbott Facial Erythema Therapies Revenue in Global Market (2018-2023)
7.9.5 Abbott Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Facial Erythema Therapies Market Opportunities & Trends in Global Market
Table 2. Facial Erythema Therapies Market Drivers in Global Market
Table 3. Facial Erythema Therapies Market Restraints in Global Market
Table 4. Key Players of Facial Erythema Therapies in Global Market
Table 5. Top Facial Erythema Therapies Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Facial Erythema Therapies Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Facial Erythema Therapies Revenue Share by Companies, 2018-2023
Table 8. Global Companies Facial Erythema Therapies Product Type
Table 9. List of Global Tier 1 Facial Erythema Therapies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Facial Erythema Therapies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Facial Erythema Therapies Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Facial Erythema Therapies Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Facial Erythema Therapies Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Facial Erythema Therapies Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Facial Erythema Therapies Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Facial Erythema Therapies Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Facial Erythema Therapies Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Facial Erythema Therapies Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Facial Erythema Therapies Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Facial Erythema Therapies Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Facial Erythema Therapies Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Facial Erythema Therapies Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Facial Erythema Therapies Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Facial Erythema Therapies Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Facial Erythema Therapies Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Facial Erythema Therapies Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Facial Erythema Therapies Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Facial Erythema Therapies Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Facial Erythema Therapies Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis Facial Erythema Therapies Product Offerings
Table 32. Novartis Facial Erythema Therapies Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Facial Erythema Therapies Product Offerings
Table 36. Pfizer Facial Erythema Therapies Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Sanofi-Aventis Company Summary
Table 39. Sanofi-Aventis Facial Erythema Therapies Product Offerings
Table 40. Sanofi-Aventis Facial Erythema Therapies Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi-Aventis Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Facial Erythema Therapies Product Offerings
Table 44. Merck Facial Erythema Therapies Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. Enzon Pharmaceuticals Company Summary
Table 47. Enzon Pharmaceuticals Facial Erythema Therapies Product Offerings
Table 48. Enzon Pharmaceuticals Facial Erythema Therapies Revenue (US$, Mn) & (2018-2023)
Table 49. Enzon Pharmaceuticals Key News & Latest Developments
Table 50. Bayer Company Summary
Table 51. Bayer Facial Erythema Therapies Product Offerings
Table 52. Bayer Facial Erythema Therapies Revenue (US$, Mn) & (2018-2023)
Table 53. Bayer Key News & Latest Developments
Table 54. Astellas Pharma Company Summary
Table 55. Astellas Pharma Facial Erythema Therapies Product Offerings
Table 56. Astellas Pharma Facial Erythema Therapies Revenue (US$, Mn) & (2018-2023)
Table 57. Astellas Pharma Key News & Latest Developments
Table 58. GSK Company Summary
Table 59. GSK Facial Erythema Therapies Product Offerings
Table 60. GSK Facial Erythema Therapies Revenue (US$, Mn) & (2018-2023)
Table 61. GSK Key News & Latest Developments
Table 62. Abbott Company Summary
Table 63. Abbott Facial Erythema Therapies Product Offerings
Table 64. Abbott Facial Erythema Therapies Revenue (US$, Mn) & (2018-2023)
Table 65. Abbott Key News & Latest Developments
List of Figures
Figure 1. Facial Erythema Therapies Segment by Type in 2022
Figure 2. Facial Erythema Therapies Segment by Application in 2022
Figure 3. Global Facial Erythema Therapies Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Facial Erythema Therapies Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Facial Erythema Therapies Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Facial Erythema Therapies Revenue in 2022
Figure 8. By Type - Global Facial Erythema Therapies Revenue Market Share, 2018-2029
Figure 9. By Application - Global Facial Erythema Therapies Revenue Market Share, 2018-2029
Figure 10. By Type - Global Facial Erythema Therapies Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Facial Erythema Therapies Revenue Market Share, 2018-2029
Figure 12. By Application - Global Facial Erythema Therapies Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Facial Erythema Therapies Revenue Market Share, 2018-2029
Figure 14. By Region - Global Facial Erythema Therapies Revenue Market Share, 2018-2029
Figure 15. By Country - North America Facial Erythema Therapies Revenue Market Share, 2018-2029
Figure 16. US Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Facial Erythema Therapies Revenue Market Share, 2018-2029
Figure 20. Germany Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 21. France Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Facial Erythema Therapies Revenue Market Share, 2018-2029
Figure 28. China Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 32. India Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Facial Erythema Therapies Revenue Market Share, 2018-2029
Figure 34. Brazil Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Facial Erythema Therapies Revenue Market Share, 2018-2029
Figure 37. Turkey Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Facial Erythema Therapies Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis Facial Erythema Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Facial Erythema Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi-Aventis Facial Erythema Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Facial Erythema Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Enzon Pharmaceuticals Facial Erythema Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bayer Facial Erythema Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Astellas Pharma Facial Erythema Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. GSK Facial Erythema Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Abbott Facial Erythema Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 顔面紅斑治療の世界市場見通し2023年-2029年(Facial Erythema Therapies Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

顔面紅斑治療の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp